Prostasin regulates iNOS and cyclin D1 expression by modulating protease‐activated receptor‐2 signaling in prostate epithelial cells
Authors:
- 7 August 2009
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 69 (16) , 1790-1801
Abstract
BACKGROUND: Prostasin is down‐regulated during inflammation and in invasive cancers, and plays a role in regulation of inflammatory gene expression and invasion.METHODS: We used the human benign prostatic hyperplasia cell line BPH‐1 to investigate gene expression changes associated with siRNA‐mediated loss of prostasin expression. Quantitative PCR and/or western blotting were used to evaluate the expression changes of iNOS, ICAM‐1, cyclin D1, IL‐6, and IL‐8. Gene expression changes were also evaluated in the presence of a PAR‐2 antagonist. The PC‐3 human prostate cancer cell line was used for evaluation of gene expression in response to prostasin re‐expression.RESULTS: Prostasin silencing in BPH‐1 was associated with up‐regulation of iNOS, ICAM‐1, IL‐6, and IL‐8, and down‐regulation of cyclin D1; as well as reduced proliferation and invasion. The iNOS up‐regulation and cyclin D1 down‐regulation associated with prostasin silencing were inhibited by a PAR‐2 antagonist. Re‐expression of prostasin, a serine active‐site mutant, and a GPI‐anchor‐free mutant, in the PC‐3 cells resulted in PAR‐2 and cyclin D1 transcription up‐regulation. Transcription up‐regulation of IL‐6 and IL‐8 was associated with re‐expression of the serine active‐site mutant prostasin in the PC‐3 cells. Transcription up‐regulation of IL‐8, but to a lesser extent, was also observed in PC‐3 cells expressing the wild‐type prostasin. Expression of a serine protease active prostasin, GPI‐anchored or anchor‐free, prevented the IL‐6 induction in response to PAR‐2. The GPI‐anchor‐free prostasin also prevented the IL‐8 induction.CONCLUSIONS: Prostasin plays a negative regulatory role on PAR‐2‐mediated signaling in prostate epithelial cells. Prostate 69: 1790–1801, 2009.Keywords
Funding Information
- Florida Biomedical Research Program (06NIR-03)
- Department of Defense (DAMD17-02-1-0032)
- Susan G. Komen for the Cure (BCTR0707538)
This publication has 56 references indexed in Scilit:
- Mite and Cockroach Allergens Activate Protease-Activated Receptor 2 and Delay Epidermal Permeability Barrier RecoveryJournal of Investigative Dermatology, 2008
- The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase–Prostasin serine protease cascade in cultured epithelial cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Kallikrein-related Peptidase 4 (KLK4) Initiates Intracellular Signaling via Protease-activated Receptors (PARs)Journal of Biological Chemistry, 2008
- Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1Biochemical and Biophysical Research Communications, 2006
- Constitutive Expression of Functionally Active Protease‐Activated Receptors 1 and 2 in Human Conjunctival Epithelial CellsMediators of Inflammation, 2006
- The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cellsBiochemical Journal, 2005
- Regulation of prostasin expression and function in the prostateThe Prostate, 2003
- Overexpression of cyclin D1 is rare in human prostate carcinomaThe Prostate, 1999
- Interaction of liposomes with cultured cells: Possible involvement of lipid peroxidation in cell growth inhibition.Chemical and Pharmaceutical Bulletin, 1990